-+ 0.00%
-+ 0.00%
-+ 0.00%

ALX Oncology Doses First Patient in Phase 2 Trial of Evorpacept for HER2-Positive Metastatic Breast Cancer

Reuters·01/08/2026 13:30:18

Please log in to view news